RSVP Now

18th Annual SoCalBio Conference

November 4, 2016— Hilton Long Beach, CA

With a CEO Reception & Dinner on November 3, from 5 to 9 pm

Thanks to Lead Sponsors

The SoCalBio Conference is an annual event organized by the Southern California Biomedical Council (SoCalBio). This conference is preceded by a CEO Reception & Dinner which will feature keynote presentations by distinguished speakers.

The SoCalBio conference showcases Southern California value-based bioscience innovations and explores efficient pathways to bring them to market. In addition to plenary sessions, business roundtables and therapeutic workshops, this conference will feature at least 40 company presentations showcasing the strength and future of the bioscience industry in Los Angeles/Orange County and neighboring communities.

Updated List of Companies Selected

to Make Presentatios to Date

• 3iDx (Developing an instrument that can provide clear identification of a specific microbe strain, including AMR strains, within an hour)
• Advanced Prenatal Therapeutics, Inc. (An Irvine-based startup using targeted apheresis to treat preeclampsia)
• ABL Denim (A Los Angeles company that makes clothing for people with disabilities that’s easier to dress in and wear more comfortably by adding functional features and technology to fashionable jeans)
• Afecta Pharmaceuticals (An Irvine company using 2D/3D computer aided molecular screening to redesign existing drug molecules and "fit" them to target drug-able proteins, metabolic pathways, diseases, and/or clinical patient subsets)
• Airware, Inc. (A Goleta company developing a non-invasive, optical monitoring device to sense interstitial glucose in the skin)
• AmberSand Biopharmaceuticals (Based in Westlake Village, AmberSand is developing a platform technology that enhances para-cellular transport by hosting drugs in a flexible micelle delivery vehicle and solubilizing the skin's lipid barrier with chemical penetration enhancers)
• Auritec Pharmaceuticals (A Pasadena Collaborative alumnus specializing in extended-release drug delivery systems)
• BioVinc (A USC spinoff developing bone targeted therapeutics & diagnostics)
• Care3 (A Los Angeles-based firm developing a digital health platform for care coordination)
• CureMatch (A San Diego-based digital health company developing a computational system for decision support in personalized cancer medicine)
• Cytolumina (A UCLA-spinoff -- now based in Agoura Hills -- that is developing a liquid biopsy platform by capturing circulating cancer cells)
• Delta Brain Inc. (A Los Angeles machine learning firm developing applications in medicine)
• . Deton Corp. (An early stage company incubated by the Pasadena Collaborative. Deton is developing a sample collection device for lower respiratory infections)
• Episona (Based in Glendale, Episona is commercializing personalized diagnostics for male infertility using epigenetics)
• Eyes 4 Lives, Inc. (A Long Beach company seeking to minimize digital eye strain and the progression of nearsightedness by correcting improper electronic usage habits)
• GNADX (Commercializing a novel iPad-controlled minicube PCR machine)
• Hillhurst Biopharmaceuticals (A Montrose-based biotech targeting debilitating inflammation)
• Kumba Health (A Beverly Hills-based digital health company developing a marketplace where providers and patients can connect)
• Mastoscopia (A USC spinoff developing a novel multimodal ultrasound tomography for breast cancer detection)
• Meditope Biosciences (A Pasadena-based, City of Hope-spinoff that is developing antibody-drug conjugates for oncological applications)
• NanoValent Pharmaceuticals (A Children's Hospital Los Angeles spinoff using a nanoparticle delivery system to target cancer)
• NeuroCore (An early-stage company developing a rapid, effective, outpatient platform for treating major depressions)
• NeuroRecovery Technologies (A UCLA spinoff developing devices for restoring movement in patients with paralysis)
• Onco Therapies (A Pasadena Collaborative firm developing a technology to remove FoxP3+ regulatory T cells and inhibit tumor growth)
• Oxeia Biopharmaceuticals (A San Diego-company researching therapeutics for brain concussion)
• PersonalRN (A Hermosa Beach-based digital health company offering personal digital RN solution that begins on admission and stays throughout the continuum of care providing personalized information for patients and their families)
• PhenoTraits (A Hermosa Beach company developing analytics to predict drug non-adherence and identify at-risk populations)
• Quantason (A Los Angeles-based company developing a dual-mode, hybrid, ultrasound-based platform for breast screening and follow-up monitoring)
• SilverGens (A Canoga Park company designing a virtual care platform called the eNURZ to increase adherence to long-term therapies in a home setting)
• STORM (Based in San Diego, STORM is developing a collaborative informatics environment that enables community-based hospitals to apply precision medicine to personalized cancer care for their patients)
• TreThera (A UCLA-spinoff developing a targeted metabolic pathway therapy that involves using a rationally-designed combination of two or three drugs from the very start for cancer treatment)